Prognostic and immunological implications of a mitophagy-associated gene signature in bladder cancer
{{output}}
Background: The pronounced heterogeneity of bladder cancer (BLCA) drives divergent patient outcomes and therapy responses. Mitophagy, a pivotal cellular quality-control and metabolic mechanism, modulates the dynamics of the tumor... ...
